Cancer Treatment Research in Oregon
Cancer Treatment Research (93.395) awarded $94.5 million to recipients in Oregon in 37 grants from fiscal 2021 to 2025, 1.7% of the program's national total. Oregon Health & Science University received the most, $76.6 million.
- Awarded in Oregon$94.5 million
- Awards37
- Share of the program1.7%
- Rank among states17th of 50
- National total$5.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 23 | $17.4 million |
| FY 2022 | 20 | $22.0 million |
| FY 2023 | 19 | $15.4 million |
| FY 2024 | 20 | $19.3 million |
| FY 2025 | 16 | $20.3 million |
Recipients in Oregon
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Oregon Health & Science University | Colleges and universities | 24 | $76.6 million |
| Providence Health & Services - Oregon | Nonprofits | 4 | $6.0 million |
| PDX Pharmaceuticals Inc | Small businesses | 2 | $4.8 million |
| Oregon State University | Colleges and universities | 2 | $2.6 million |
| Children's Cancer Therapy Development Institute | Nonprofits | 1 | $1.5 million |
| Inherent Targeting, LLC | Small businesses | 1 | $1.4 million |
| Madorra Inc | Small businesses | 1 | $848,451 |
| University of Portland | Colleges and universities | 1 | $404,168 |
| Veana Therapeutics Inc. | Small businesses | 1 | $394,676 |
Open opportunities under this program
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Treatment Research money goes to Oregon?
$94.5 million from fiscal 2021 to 2025, across 37 awards. Oregon ranks 17th of 50 states and territories for this program.
Who receives Cancer Treatment Research money in Oregon?
The largest recipient is Oregon Health & Science University, with $76.6 million in 24 awards. Next are Providence Health & Services - Oregon and PDX Pharmaceuticals Inc.
Can organizations in Oregon apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Treatment Research in other states
Other large programs in Oregon
- Grants to States for Medicaid
- Highway Planning and Construction
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Education Stabilization Fund
- National School Lunch Program
- Federal Transit Formula Grants
- Head Start
- Temporary Assistance for Needy Families
- Child Care and Development Block Grant